ES2193272T3 - Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. - Google Patents
Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen.Info
- Publication number
- ES2193272T3 ES2193272T3 ES96939131T ES96939131T ES2193272T3 ES 2193272 T3 ES2193272 T3 ES 2193272T3 ES 96939131 T ES96939131 T ES 96939131T ES 96939131 T ES96939131 T ES 96939131T ES 2193272 T3 ES2193272 T3 ES 2193272T3
- Authority
- ES
- Spain
- Prior art keywords
- lys
- lysine
- conjugates
- compositions
- contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
LA INVENCION SE REFIERE A LOS CONJUGADOS PEPTIDICOS QUE CONTIENEN UNA SECUENCIA DE AL MENOS 3 AMINOACIDOS ELEGIDOS ENTRE LYS-LYS-GLY, GLY-HIS-LYS Y GLU-HIS-LYS, EN LA CUAL "LYS" REPRESENTA LA LISINA O UN DERIVADO HALOGENADO DE LA LISINA O UN DERIVADO METILADO DE LA LISINA, EN PARTICULAR LA METIL LISINA Y LA DIHIDROBROMOMETIL LISINA; LOS AMINOACIDOS PUEDEN ENCONTRARSE EN LAS FORMAS D, L O DL; DICHA SECUENCIA ESTA CONJUGADA QUIMICAMENTE O FISICAMENTE CON AL MENOS UN COMPUESTO SELECCIONADO ENTRE LOS ACIDOS MONOCARBOXILICOS DE FORMULA GENERAL (Y): HOOC R, ASI COMO SUS DERIVADOS ALCOHOL, ALDEHIDO O AMIDA; LOS ACIDOS DICARBOXILICOS DE FORMULA GENERAL (II): HOOC - R 1 - COOH. SE REFIERE ASIMISMO A SU UTILIZACION COMO MEDICAMENTOS Y A LAS COMPOSICIONES FARMACEUTICAS O COSMETICAS QUE LOS CONTIENEN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9513543A FR2741075B1 (fr) | 1995-11-15 | 1995-11-15 | Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2193272T3 true ES2193272T3 (es) | 2003-11-01 |
Family
ID=9484595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96939131T Expired - Lifetime ES2193272T3 (es) | 1995-11-15 | 1996-11-15 | Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0869969B1 (es) |
JP (1) | JP2000512613A (es) |
AT (1) | ATE235508T1 (es) |
AU (1) | AU7683196A (es) |
CA (1) | CA2237993A1 (es) |
DE (1) | DE69627019T2 (es) |
ES (1) | ES2193272T3 (es) |
FR (1) | FR2741075B1 (es) |
WO (1) | WO1997018235A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001992B2 (en) | 1997-05-30 | 2006-02-21 | Human Genome Sciences, Inc. | Antibodies to secreted protein HEMCM42 |
ATE487737T1 (de) * | 1997-05-30 | 2010-11-15 | Human Genome Sciences Inc | 32 humane sekretierte proteine |
FR2802413B1 (fr) * | 1999-12-17 | 2003-10-31 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause |
FR2810323B1 (fr) * | 2000-06-16 | 2002-09-06 | Shiseido Int France | Utilisation cosmetique d'un lipopeptide |
KR100753472B1 (ko) * | 2002-03-15 | 2007-08-31 | 주식회사 엘지생활건강 | 사람 콜라겐 ⅰ형의 c-말단에서 유래된 펩타이드에tat 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물 |
FR2857667B1 (fr) | 2003-07-18 | 2007-07-13 | Inst Europ Biolog Cellulaire | Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie |
FR2857597B1 (fr) * | 2003-07-18 | 2008-01-25 | Inst Europeen Biolog Cellulair | Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie. |
KR101228239B1 (ko) | 2004-03-26 | 2013-01-30 | 디에스엠 아이피 어셋츠 비.브이. | 화장품용 아릴알킬산의 아미노산 및 펩타이드 공액체 |
FR2870244B1 (fr) * | 2004-05-11 | 2011-01-07 | Centre Nat Rech Scient | Conjugues dipeptidiques antagonistes de l'alpha-msh |
FR2913603A1 (fr) * | 2007-03-15 | 2008-09-19 | Michel Yvan Hocquaux | Composition cosmetique destinee au soin de peaux agressees par un traitement esthetique tel qu'intervention chirurgicale,traitement lasers,dermabrasion,peeling. |
WO2009003283A1 (en) * | 2007-06-29 | 2009-01-08 | Innovactiv Inc. | Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
US20100310484A1 (en) * | 2007-06-29 | 2010-12-09 | Innovactiv Inc. | Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
EP2165698B8 (fr) | 2008-09-18 | 2016-12-07 | Universkin | Composition cosmétique destinée au soin de peaux agressées |
US7928067B2 (en) | 2009-05-14 | 2011-04-19 | Ischemix Llc | Compositions and methods for treating ischemia and ischemia-reperfusion injury |
DE102009055970B4 (de) * | 2009-11-27 | 2014-04-17 | Marcus Asam | Kosmetische Wirkstoffzubereitung |
JP2014502264A (ja) | 2010-11-18 | 2014-01-30 | イスケミックス エルエルシー | リポイル化合物および虚血性傷害を治療するためのその使用 |
FR2986528B1 (fr) * | 2012-02-06 | 2015-12-04 | Inst Europeen Biolog Cellulair | Nouveaux peptides antivieillissement |
JP7203756B2 (ja) | 2017-04-25 | 2023-01-13 | イスケミックス エルエルシー | 外傷性脳傷害を治療するための組成物および方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5120831A (en) * | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
US5118665A (en) * | 1990-02-09 | 1992-06-02 | Procyte Corporation | Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
DE4127790A1 (de) * | 1991-08-22 | 1993-02-25 | Wank Anna | Verwendung von oligopeptiden mit 2 bis 5 peptidbindungen fuer kosmetische zwecke und einige neue oligopeptid-metallkomplexe |
-
1995
- 1995-11-15 FR FR9513543A patent/FR2741075B1/fr not_active Expired - Fee Related
-
1996
- 1996-11-15 DE DE69627019T patent/DE69627019T2/de not_active Expired - Fee Related
- 1996-11-15 CA CA002237993A patent/CA2237993A1/fr not_active Abandoned
- 1996-11-15 AU AU76831/96A patent/AU7683196A/en not_active Abandoned
- 1996-11-15 ES ES96939131T patent/ES2193272T3/es not_active Expired - Lifetime
- 1996-11-15 EP EP96939131A patent/EP0869969B1/fr not_active Expired - Lifetime
- 1996-11-15 AT AT96939131T patent/ATE235508T1/de not_active IP Right Cessation
- 1996-11-15 JP JP09518638A patent/JP2000512613A/ja not_active Ceased
- 1996-11-15 WO PCT/FR1996/001811 patent/WO1997018235A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
FR2741075B1 (fr) | 1998-01-30 |
DE69627019D1 (de) | 2003-04-30 |
JP2000512613A (ja) | 2000-09-26 |
EP0869969B1 (fr) | 2003-03-26 |
FR2741075A1 (fr) | 1997-05-16 |
DE69627019T2 (de) | 2004-01-22 |
ATE235508T1 (de) | 2003-04-15 |
WO1997018235A1 (fr) | 1997-05-22 |
AU7683196A (en) | 1997-06-05 |
CA2237993A1 (fr) | 1997-05-22 |
EP0869969A1 (fr) | 1998-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193272T3 (es) | Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. | |
DE69327057T2 (de) | Polyarylate, die derivate der natürlichen aminosäure l-tyrosin enthalten | |
DE69535963D1 (de) | LHRH antagonistische Peptide | |
ES2196187T3 (es) | Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen. | |
ATE308998T1 (de) | Langwirkende arzneistoffe und diese enthaltende arzneimittel | |
ATE217884T1 (de) | Pentapeptid-methylester, die menschliche krebs hemmen | |
BR9611367A (pt) | Formulação farmacêutic liofilizada estável | |
DE69428040T2 (de) | Orale darreichungsform | |
TR199501669A1 (tr) | Peptid ve proteinlerin aerosol formülasyonlari. | |
DE69635720D1 (de) | Pharmazeutische Zusammensetzungen von Cyclosporine mit einer Polyethoxylierten hydroxy-fettsäure | |
DK0589843T3 (da) | Cyclosporinholdige farmaceutiske præparater | |
DE59711873D1 (de) | Pharmazeutische zusammensetzung für die immunmodulation beruhend auf peptiden und adjuvantien | |
TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
IT1244548B (it) | Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche | |
ATE131383T1 (de) | Arzneimittel | |
BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
NO902871L (no) | Fremgangsmaate for innfoering av et peptid i cytosol. | |
RS49772B (sr) | Farmaceutske kompozicije | |
ATE276272T1 (de) | Entzündungshemmende peptide | |
DE3882233D1 (de) | Gefaessaktive peptide. | |
ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
SE9101586D0 (sv) | Modified thioredoxin and its use | |
KR970058720A (ko) | 향균 및 항진균 활성을 갖는 펩타이드 | |
TH35998A (th) | Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น |